Gauging the Continued Impact of the Novel Coronavirus Across the Global IP Market: Compulsory Licensing and March-In Rights in the Age of COVID-19

July 21, 2021 11:15am

Meaghan Richmond
Assistant General Counsel
AstraZeneca

Kevin Noonan
Partner
McDonnell Boehnen Hulbert & Berghoff LLP

  • Assessing how the search for a Covid-19 cure has affected drug development and patent prosecution
  • Examining the measures being undertaken by patent offices around the world with regard to Covid-19 related patents and how they will impact patent prosecution and examination
  • Exploring the potential impact that government use provisions and Bayh-Dole “march in rights” will have on life science companies developing pharmaceuticals and medical devices to address the current COVID-19 pandemic
  • Exploration of applicable compulsory licensing laws around the world